Healthcare -
Biotechnology - NASDAQ - US
$ 5.01
5.92 %
$ 322 M
Market Cap
-5.06
P/E
Price Target
Average
127.54%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
25.99%
Net Income
Estimate
50.68%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Corvus Pharmaceuticals, Inc.
Wall Street analysts predict an average 1-year price target for CRVS of $11.4 , with forecasts ranging from
a
low of
$7 to a high of $13 .
CRVS Lowest Price Target
Wall Street Target
7 USD
39.72%
CRVS Average Price Target
Wall Street Target
11.4 USD
127.54%
CRVS Highest Price Target
Wall Street Target
13 USD
159.48%
REVENUE FORECAST
Revenue Forecast Chart CRVS
EBIT FORECAST
EBIT Forecast Chart CRVS
NET INCOME FORECAST
Net Income Chart CRVS